Bard Associates’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
Bard Associates's BNTX Position: Q3 2026 in Review
Bard Associates opened a new position in BioNTech (BNTX) in Q3 2026: 300 shares worth $29.5K. The stake represents 0.01% of the portfolio and ranks #215 among its holdings.
297 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.
- Bard Associates held 300 shares of BioNTech worth $29.5K as of Q3 2026.
- BioNTech was a new Bard Associates position in Q3 2026.
- BioNTech made up 0.01% of Bard Associates's portfolio in Q3 2026, its #215 holding.
- 297 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.
Based on Bard Associates's 13F filing for Q3 2026, filed 13 Nov 2026.